JPMorgan analyst Eric Joseph downgraded HilleVax to Neutral from Overweight with a price target of $5, down from $24.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLVX:
Education
About Us
Working with TipRanks
Follow Us
